Bessemer Group Inc. Sells 6,462 Shares of The Clorox Company $CLX

Bessemer Group Inc. cut its position in shares of The Clorox Company (NYSE:CLX) by 43.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,307 shares of the company’s stock after selling 6,462 shares during the period. Bessemer Group Inc.’s holdings in Clorox were worth $861,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of CLX. Allspring Global Investments Holdings LLC increased its holdings in shares of Clorox by 3.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 5,237 shares of the company’s stock worth $546,000 after acquiring an additional 177 shares during the last quarter. Independent Financial Group LLC bought a new stake in Clorox in the 1st quarter valued at $420,000. Wealthfront Advisers LLC lifted its holdings in Clorox by 18.5% during the 1st quarter. Wealthfront Advisers LLC now owns 3,690 shares of the company’s stock valued at $382,000 after purchasing an additional 575 shares during the last quarter. D.A. Davidson & CO. boosted its position in Clorox by 8.8% during the first quarter. D.A. Davidson & CO. now owns 20,674 shares of the company’s stock worth $2,142,000 after purchasing an additional 1,676 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in Clorox by 2.3% during the first quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock worth $132,670,000 after purchasing an additional 29,181 shares during the period. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research reports. TD Cowen raised their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $94.00 price target on shares of Clorox in a report on Wednesday. Evercore restated an “underperform” rating and set a $98.00 price objective on shares of Clorox in a research report on Thursday. Morgan Stanley reduced their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Finally, Royal Bank Of Canada decreased their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average price target of $102.80.

Clorox Trading Down 2.0%

Shares of CLX stock opened at $93.81 on Friday. The stock has a market cap of $11.34 billion, a P/E ratio of 15.23 and a beta of 0.54. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.00. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a 50 day simple moving average of $95.00 and a 200 day simple moving average of $103.89.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts predict that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.63% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.